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Abstract
Alveolar echinococcosis (AE) of human being caused by Echinococcus multilocularis is a rare but important
zoonosis especially in tempered zones of middle Europe and Northern America with endemic character in many
countries. Due to the long incubation period, various clinical manifestations, critical prognosis, and outcome AE
presents a serious and severe disease. The primary focus of infection is usually the liver. Although secondary
affection of visceral organs is possible extrahepatic AE is highly uncommon. Moreover, the involvement of bone
and muscle presents with an even lower incidence. In the literature numerous cases on hepatic AE have been
reported. However, extrahepatic AE involving bones and/or muscles was described very rarely. We report a case of
an 80-year-old man with primary extrahepatic alveolar Echinococcosis of the lumbar spine and the psoas muscle.
The etiology, diagnosis, differential diagnoses, treatment options and outcome of this rare disease are discussed in
context with the current literature.
Introduction
Two types of Echinococcus species are known - Echino-
coccus granulosus (EG) and Echinococcus multilocularis
(EM). EG causes cystic Echinococcosis (CE) while EM
causes alveolar Echinococcosis (AE) [1-3]. AE is one of
the most pathogenic zoonoses in the northern hemi-
sphere with an annual incidence of 0.03 to 1.2 per
100.000 inhabitants [4,5]. In Europe EM is endemic in
Belgium, Luxembourg, France, Switzerland, Liechten-
stein, Germany, Austria, Italy, Poland, and the Czech
Republic. Latest epidemiology research on EM in Eur-
ope revealed additional endemic regions within urban
and suburban areas. This seems to be due to increasing
prevalence of EM in foxes (Vulpes vulpes), the primary
host [4,6]. Besides foxes, dogs and cats, also domestic
pigs might be affected by EM [3].
Usually, the primary infection site of AE is the liver.
However, it can spread into extrahepatic structures and
metastasize like a tumorous disease even to remote
organs such as brain and heart. The incubation time
ranges from five up to fifteen years [1,7]. Owing to its
infiltrating and metastasizing character, AE is clinically
staged according to the Primary-tumor-Nodes-Metasta-
sis-system (PNM)-system. It is based on the extent of
the hepatic lesion, the affection of adjacent organs as
well as the number and extent of metastases [1] (see
table 1). AE usually metastasizes to pancreas, spleen,
retroperitoneum, lung, brain, but also to bone and soft
tissue [8]. Gottstein et al. described an occurrence of
metastasis in up to 20%, especially in lung and brain [9].
While pulmonary metastases occur in 7 to 20%, cerebral
metastases are only described in 1 to 3% [1,5]. Osseous
affection is uncommon, occurring in up to 1% of all
cases [10]. To the best of our knowledge only 18 cases
of osseous AE have been reported so far [11,12]. Pri-
mary extrahepatic manifestation of AE seems to be
absolutely unusual and extremely rare.
In this context we present the case of a primary extra-
hepatic AE, affecting the lumbar spine and the psoas
muscle. We discuss the etiology, diagnosis, and therapy
of this rare lesion based on the current literature.
Case history
An 80-year-old man presented with sudden onset of
right upper and lower quadrant abdominal pain at an
academic department for surgery in October 2009. In
addition, he suffered from relapsing nausea and
* Correspondence: kirchhoff@lrz.tu-muenchen.de
1Department of Orthopaedics and Traumatology, Technische Universität
München, Klinikum Rechts der Isar, Ismaninger Str. 22, D-81675 Munich,
Germany
Full list of author information is available at the end of the article
Nell et al. Annals of Clinical Microbiology and Antimicrobials 2011, 10:13
http://www.ann-clinmicrob.com/content/10/1/13
© 2011 Nell et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.vomiting, also describing recurrent low-grade fever a
few days before and subjective feeling of swelling of the
right upper abdomen. Written informed consent was
obtained from the patient for publication of this case
report and accompanying images. Computed tomogra-
phy (CT) of the abdomen was performed revealing sev-
eral cystic lesions of different size in the right psoas
muscle. At that time, abscess-like formations were con-
sidered to be the most likely diagnosis. Considering this
the working diagnosis initial treatment included the
intravenous administration of antibiotics - Piperacillin/
Tazobactam - and the percutaneous drainage of the big-
gest abscess under CT guidance. A follow-up CT-scan
showed a diminution of the drained abscess followed by
clinical recovery. Therefore, another percutaneous drai-
nage of another, smaller abscess was performed. This
led to shrinkage of the lesion and further clinical recov-
ery. The inflammatory parameters decreased and no
microorganisms were detected in the drained fluid. Sub-
sequently the patient was discharged home.
One week later, the patient presented with recurrent
abdominal pain in the right lower quadrant at the same
department he had initially turned to. An abdominal
ultrasound showed several obvious abscesses in the right
psoas muscle. After readmission, three CT-guided suc-
tion drainages were placed in the three biggest abscesses.
The microbiological analysis of the drained liquid pro-
vided evidence of Staphylococcus aureus. Hence antibio-
tic treatment was restarted with Piperazillin/Tazobactam.
Despite continuous drainage for 7 days a follow-up CT
revealed size constancy of the abscesses. Therefore, sur-
gery was indicated and an open debridement of the
abscesses in the right psoas muscle with resection of pan-
nus was performed. The intraoperative microbiological
work-up proved Staph. epidermidis and Staph. warneri.
Thus, the antibiotic treatment with Piperacillin/Tacobac-
tam was continued with higher dose rate. The patient’s
general condition improved and he could be discharged
to rehabilitation 22 days after readmission.
D u r i n gr e h a b i l i t a t i o nh es u f f e r e df r o mr e c u r r e n tr i g h t
lower quadrant abdominal pain and therefore he was
readmitted again. After readmission a CT-scan revealed
a new multilobulated cystic lesion in the right psoas
muscle (see figure 1). Again a suction drainage was
placed in the biggest abscess-like lesion and purulent
fluid was obtained. The cultivation of the drained fluid
revealed growth of Staph. lugdunensis. Therefore the
antibiotic treatment was changed to Amoxicillin. Owing
to drug hypersensitivity, the treatment had to be chan-
ged to Vancomycine and Zyvoxid. During hospitaliza-
tion the patient developed additional pain in the upper
lumbar spine from lumbar vertebrae L1 to L3 without
neurological deficit. Simultaneously the general health
condition of the patient worsened. A CT examination of
the lumbar spine showed geographic bone destruction
and inhomogeneous osteolysis of the lumbar vertebra
L1 to L3 without soft tissue involvement, leading to the
diagnosis of osteomyelitis (see figure 1 and 2).
Hence, the patient was transferred to our academic
department for orthopaedics and traumatology for
further treatment. The range of motion of the right hip
joint was painfully reduced and there was a positive
psoas sign. The patient’s general condition was poor and
he showed a lack of appetite with consecutive weight
Table 1 The PNM classification of alveolar echinococcosis
P Hepatic localization of the parasite
PX Primary tumor cannot be assessed
P0 No detectable tumor in the liver
P1 Peripheral lesions without proximal vascular and/or biliary involvement
P2 Central lesions with proximal vascular and/or biliary involvement of one lobe (a)
P3 Central lesions with hilar vascular or biliary involvement of both lobes and/or with involvement of two hepatic veins
P4 Any liver lesion with extension along the vessels (b) and the biliary tree
N Extra-hepatic involvement of neighboring organs [diaphragm, lung, pleura, pericardium, heart, gastric and duodenal wall, adrenal glands,
peritoneum, retroperitoneum, parietal wall (muscles, skin, bone), pancreas, regional lymph nodes, liver ligaments, kidney]
NX Not evaluable
N0 No regional involvement
N1 Regional involvement of contiguous organs or tissues
M The absence or presence of distant Metastasis [lung, distant lymph nodes, spleen, CNS, orbita, bone, skin, muscle, kidney, distant peritoneum
and retroperitoneum]
MX Not completely evaluated
M0 No metastasis (c)
M1 Metastasis
(a) For classification, the plane projecting between the bed of the gall bladder and the inferior vena cava divides the liver in two lobes
(b) Vessels mean inferior vena cava, portal vein and arteries
(c) Chest X-ray and cerebral CT negative
Nell et al. Annals of Clinical Microbiology and Antimicrobials 2011, 10:13
http://www.ann-clinmicrob.com/content/10/1/13
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was normal. The physical examination was unremarkable.
Only pressure pain to the right lower quadrant of the
abdomen and percussion tenderness at the level of the
lumbar vertebrae L1 to L3 was revealed. Therefore surgical
revision was indicated; during surgery tubular cavities
were detected macroscopically (see figure 3) and for the
first time Echinococcosis was suspected. A subtotal resec-
tion of the right psoas muscle was performed due to the
multitude of obvious parasitic lesions. The lumbar verteb-
rae L1 to L3 were removed and then filled up with poly-
methylmethacrylate bone cement (PMMA). The
microbiological examination did not reveal any microor-
ganisms. However the histopathological examination
showed typical parasitic vesicles consistent with Echino-
coccosis, which were delineated by a Periodic-Acid-Schiff
(PAS+) laminated layer test. The postoperative serology
was highly positive for AE. In addition, polymerase chain
reaction (PCR) was conducted and specific nucleic acids of
EM were detected. Thus the antibiotic treatment was
stopped and a continuous Benzimidazole therapy with
Albendazole 400 mg twice per day was started immedi-
ately. In the course of the disease the patient’s general con-
dition improved and finally the inflammatory parameters
totally declined. The patient showed great improvement
regarding mobilization. A follow-up CT- and MR-
examination was performed one month after the begin-
ning of continuous Benzimidazole treatment. The images
revealed no parasitic residua in the right psoas muscle, but
little cystic residua in the first lumbar vertebra were
depicted. Furthermore, a postoperative hematoma anterior
Figure 1 Computed tomography scans of the abdomen and
pelvis. Non-enhanced (A) and contrast-enhanced (B) axial images
show a multilobulated cystic mass in the right retroperitoneum,
originating from the psoas muscle. Besides of the cystic
components with fluid-like density (*) thickened septa with mild
contrast enhancement (arrow) are seen. The coronal image (C)
shows the extent of the mass along the psoas muscle. (D) The
lumbar spine presents lytic lesions of the first and second lumbar
vertebra (arrows) with partial cortical destruction.
Figure 2 Magnetic Resonance Imaging of the lumbar spine. (A)
The T2-weighted axial MR image shows multiple small hyperintense
lesions in the right psoas muscle (arrows). The corresponding fat-
suppressed T1-weighted image after gadolinium administration (B)
confirmed the diagnosis of a multicystic mass and delineated the
thickened, contrast-enhancing septations around the cystic
components (arrow). T1-weighted image (C) and T2-weighted STIR
image (D) of the lumbar spine in sagittal orientation. These images
showed the bone marrow replacement within the first, second, and
third lumbar vertebrae (arrows). The lesions comprise of cystic and
solid components.
Figure 3 Photograph of the resected specimen demonstrates
the macroscopic appearance of the multivesicular hydatid cyst.
The typical “bunch of grapes” appearance is visible; moreover it is
obvious that the hydatid cyst has three layers.
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lesions were found. An additional cerebral CT did not
show any pathological findings. Finally the patient could
be discharged for rehabilitation.
Discussion
AE represents an important endemic parasitic zoonosis
in the northern hemisphere [1]. Owing to its late onset
and various clinical features a certain delay until definite
diagnosis is common and AE is often found incidentally.
In the present case the patient reported a long history
of abdominal discomfort and pain with additional relap-
sing nausea, vomiting, fever, and a subjective feeling of
swelling. The symptoms and clinical signs depend on
the structures and/or organs affected. Therefore, the
clinical presentation of AE is highly variable and not
specific [13]. In hepatic affection the symptoms include
cholestatic jaundice and/or abdominal pain. Further
symptoms are fatigue and weight loss [2].
X-ray and CT findings of osseous AE are unspecific.
I n h o m o g e n e o u so s t e o l y s i sa n di r r e g u l a rb o n ed e s t r u c -
tion may be seen. In the soft tissues, CT can reveal cys-
tic masses with irregular thickened septations [14].
Magnetic resonance imaging (MRI) may show tube-like
cavities/cystic lesions with a multi-vesicular morphology
if soft tissue is infected. Diagnostic criteria for cystic
lesions are high intensity on T2-weighted images and
low intensity on T1-weighted images without contrast
agent enhancement (see figure 2). Because of the con-
trast enhancing thickened margins and septations AE
can easily be confused with abscess formations [15,16].
In this context the multiple cyst-like formations in the
right psoas muscle were initially considered as bacterial
psoas abscesses (BIA). Since BIA are common in the
elderly population, this diagnosis seemed to be corrobo-
rated at first [17]. Moreover, antibiotic treatment and
percutaneous drainage lead to a diminution of the
abscess formation and improved general health status.
Additionally the diagnosis of BIA was even more corro-
borated because of the growth of various Staph. species.
According to Ricci et al. Staph. aureus is known as the
most common microorganism with an incidence of over
88% in patients suffering from BIA [17,18]. In parallel to
AE BIA also cause unspecific clinical symptoms
[17,19-21]. The classic clinical triad of fever, back and
limb pain is present in only 30% of the patients with
BIA [17]. Regarding etiology BIA is related with diabetes
mellitus, intravenous drug abuse, AIDS, renal failure
and immunosuppression [17,22]. Vertebral osteomyelitis,
septic arthritis or infectious sacroiliitis may also cause
BIA [17,22].
In the present case, the patient developed lumbar back
pain. The CT examination of the lumbar spine was
interpreted as vertebral osteomyelitis. Therefore, therapy
included antibiotic medication and percutaneous drai-
nage. These management strategies are recommended
for treatment of BIA [6,18-21,23,24]. Because of failure
of the percutaneous drainage open surgery was per-
formed in the further course.
The intraoperative aspect of tube-like cavities in the
psoas muscle raised the suspicion for Echinococcosis.
Finally the presence of AE was confirmed by histo-
pathology and laboratory setup. In addition to the radi-
ological and macroscopic presentation the diagnosis of
AE is based on serology and PCR [11]. Histopathology
typically reveals parasitic vesicles delineated by a Peri-
odic-Acid-Schiff (PAS+) laminated layer [2,10]. The
periparasitic granuloma is composed of epitheloid cells
lining the parasitic vesicles, macrophages, fibroblasts
and myofibroblasts, giant multinucleated cells, and cells
of the nonspecific immune response, surrounded by
lymphocytes [2].
I nt h ep r e s e n tc a s et h ep o s t o p e r a t i v es e r o l o g yw a s
positive for AE. For serological diagnosis purified,
recombinant or in-vitro produced E. multilocularis anti-
gens are used, mainly Em2, Em2+ and Em18 (2). Em10
is an E. multilocularis specific recombinant antigen used
for assays to confirm AE [1]. According to the literature
serology has a high sensitivity of 90 to 100% and a spe-
cificity of 95 to 100% [2]. Carmena et al. described high
sensitivity and specificity of serological tests ranging
from 75 to 100% [25]. The differentiation between E.
multilocularis and E. granulosus is possible in 80 to 95%
of cases using most of the purified antigens [2]. Never-
theless serological interpretation can be difficult in dis-
ease with extrahepatic infestation and sometimes
remains insufficient in differentiating AE from CE. Espe-
cially the use of total somatic antigens is considered to
show a high degree of cross-reaction with other para-
sites [11]. In contrast, Gottstein et al. described
improved immunodiagnostic with Em2+ ELISA using
purified species-specific antigens
9.T h eW e s t e r nb l o t
detects serum IgG in 97% of patients infected with Echi-
nococcus and its sensitivity is higher than of the ELISA
for the detection of Echinococcosis [11]. However, it
can distinguish E. multilocularis from E. granulosus in
only 76% of cases.
In our patient, PCR was conducted additionally in tis-
sue specimens resected from the psoas muscle and the
lumbar vertebrae. The result was equal 100% for the
presence of E. multilocularis. The aim of PCR is to
detect specific nucleic acids of Echinococcus and conse-
quently to differentiate E. multilocularis from E. granu-
losus. So PCR is increasingly accepted as a
complementary diagnostic tool for Echinococcosis and
has been used to confirm the pathology in unusual loca-
tions [1]. Scheuring et al. were successful differentiating
E. multilocularis and E. granulosus in a patient with
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described two cases of extrahepatic osseous infestation
w h e r eP C Rw a su s e f u lt od i a g n o s eA Eb e c a u s eo fl i m -
ited serological interpretation [11].
Regarding medical history, vocational or part-time
farming, gardening, forestry and hunting are known risk
factors for a possible infection with AE [5]. 559 patients
were reported to the European Echinococcosis registry
from 1982 to 2000 on a voluntary basis. 61.4% of 210
registered persons presented with risk factors as listed
[5]. Therapy of AE should be multidisciplinary addres-
sing every potential organ affection. Early diagnosis is
crucial for prognosis and outcome as mortality reaches
up to 80% in untreated patients [27]. In Europe therapy
has changed average life expectancy at time of diagnosis
from 3 years in the 1970s to 20 years in 2005 [2].
Although the introduction of Benzimidazole in the early
1980s brought an eminent breakthrough in treatment of
AE and CE, surgical therapy is mandatory [28]. When-
ever possible complete resection of AE lesions should be
performed [2]. Because of the infiltrating growth of
parasitic tissue and the potential for metastases princi-
ples and rules of tumor surgery should be considered
and followed. Unfortunately most patients are inoper-
able at the time of diagnosis [29]. In the present case a
subtotal resection of the right psoas muscle was per-
formed due to the multitude of parasitic lesions and we
removed the lumbar vertebrae 1 to 3 and filled them up
with bone cement.
Although postoperative Benzimidazole therapy is man-
datory in all patients, there is no commonly accepted
guideline regarding pre-surgical drug therapy and dura-
tion of drug treatment. Some authors suggest that tem-
porary treatment might be sufficient after complete
resection [2]. Reuter et al. recommend a Benzimidazole
treatment for at least two years since residual parasitic
tissue may remain undetected [30]. In case of incom-
plete surgical resection and in inoperable patients long-
term or even life-long Benzimidazole therapy is indi-
cated [2]. Recent studies clearly demonstrated a signifi-
cant improvement of the 10-year survival rate in non-
radically resected patients who received a long term
Benzimidazole therapy in comparison to a historic con-
trol group [31]. This is in line with the recommendation
of Brunetti et al. suggesting lifelong Benzimidazole ther-
apy in non-radically resected patients [2].
Follow-up of infected patients is crucial. This includes
imaging in terms of CT and MRI at intervals of 2-3
years and ultrasound at shorter intervals, blood tests
with determination of Albendazole blood levels and ser-
ological tests. Serological analysis in the follow-up pre-
sents a close relationship between clinical status and
treatment of patients with AE although interpretation of
serological tests in patients under Benzimidazole
treatment but without complete resection is more com-
plex [32]. Scheuring et al. demonstrated that anti-Em2-
and anti-Em18-antibodies rapidly decreased after com-
plete resection of parasitic lesions and become undetect-
able [26].
Conclusion
In summary, primary extrahepatic AE of bone and mus-
cle is an extremely rare disease. The clinical course lead-
ing to diagnosis can be long and difficult because of the
various and unspecific clinical features. As in the case
described psoas muscle abscesses are an important dif-
ferential diagnosis. Recrudescent reappearance of
obvious abscesses in a patient’sh i s t o r yd e s p i t eo ft h e
continuous administration of antibiotics and percuta-
neous drainage for several times has to direct one’s
attention to the possible presence of Echinococcosis. If a
patient is suspected of having Echinococcosis imaging
should be completed and serological tests and PCR
should be done immediately. Early diagnosis is very
important for prognosis and outcome and a multidisci-
plinary approach of treatment should be followed. Sur-
gery and drug therapy are available options for
treatment.
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